Table 2. Proteins identified in lung cancer cohort Nasosorption FX-i samples.

Excel file containing proteins identified in the lung cancer cohort described in Chapter 5 of the thesis entitled: "The Nasal Proteome as a Source of Biomarkers for SARS-CoV-2 and Lung Cancer". Tabs containing proteins identified in all samples, unique to individual disease groups and present in two of three disease groups. 

Nasal mucus from Nasosorption FX-i devices from patients with lung cancer, post-lung cancer resection and matched controls was eluted and processed for mass spectrometry analysis using S-Trap. Samples were analysed in a data-dependent manner and subsequently analysed using Proteome Discoverer software.

包含于题为《鼻咽蛋白质组作为SARS-CoV-2及肺癌生物标志物的来源》的论文第五章中所述肺癌队列中鉴定出的蛋白质的Excel文件。该文件包含所有样本中鉴定出的蛋白质、仅特定于各个疾病组以及存在于两组中的三组疾病组的独特蛋白质。来自患有肺癌、肺癌切除术后以及匹配对照者的Nasosorption FX-i设备中的鼻咽分泌物经过洗脱和S-Trap质谱分析处理。样本以数据依赖的方式进行分析，随后使用蛋白质组发现者软件进行进一步分析。